{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:51:17Z","timestamp":1761562277190,"version":"3.40.5"},"reference-count":26,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Institutes of Health T32 postdoctoral research training grant","award":["T32-HL007853"],"award-info":[{"award-number":["T32-HL007853"]}]},{"name":"Blue Cross Blue Shield of Michigan and Blue Care Network"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ajconline.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.amjcard.2017.08.009","type":"journal-article","created":{"date-parts":[[2017,8,31]],"date-time":"2017-08-31T00:00:16Z","timestamp":1504137616000},"page":"1926-1932","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Ninety-Day Readmission and Long-Term Mortality in Medicare Patients (\u226565 Years) Treated With Ticagrelor Versus Prasugrel After Percutaneous Coronary Intervention (from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium)"],"prefix":"10.1016","volume":"120","author":[{"given":"Chris","family":"Song","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4709-3390","authenticated-orcid":false,"given":"Devraj","family":"Sukul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milan","family":"Seth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4290-9648","authenticated-orcid":false,"given":"James M.","family":"Dupree","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akshay","family":"Khandelwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon R.","family":"Dixon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Wohns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"LaLonde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitinder S.","family":"Gurm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2017.08.009_bib0010","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2017.08.009_bib0015","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2017.08.009_bib0020","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1161\/CIRCULATIONAHA.116.024823","article-title":"Prasugrel versus ticagrelor in patients with acute myocardial infarction treated with primary percutaneous coronary intervention: clinical perspective","volume":"134","author":"Motovska","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2017.08.009_bib0025","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/ccd.26279","article-title":"\u201cReal-world\u201d comparison of prasugrel with ticagrelor in patients with acute coronary syndrome treated with percutaneous coronary intervention in the United States","volume":"88","author":"Larmore","year":"2016","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2017.08.009_bib0030","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000447396","article-title":"Real-world use of novel P2Y12 inhibitors in patients with acute myocardial infarction: a treatment paradox","volume":"136","author":"Beigel","year":"2016","journal-title":"Cardiology"},{"key":"10.1016\/j.amjcard.2017.08.009_bib0035","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1161\/CIRCINTERVENTIONS.113.000475","article-title":"Risk stratification for long-term mortality after percutaneous coronary intervention","volume":"7","author":"Wu","year":"2014","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2017.08.009_bib0040","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jcin.2012.10.015","article-title":"Readmission in the 30 days after percutaneous coronary intervention","volume":"6","author":"Yost","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2017.08.009_bib0045","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","article-title":"Heart Disease and Stroke Statistics\u20142017 Update: a report from the American Heart Association","volume":"135","author":"Benjamin","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2017.08.009_bib0050","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1540-8183.2002.tb01072.x","article-title":"Development of a multicenter interventional cardiology database: the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) experience","volume":"15","author":"Kline-Rogers","year":"2002","journal-title":"J Intervent Cardiol"},{"key":"10.1016\/j.amjcard.2017.08.009_bib0055","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1161\/CIRCULATIONAHA.105.541995","article-title":"Association of a continuous quality improvement initiative with practice and outcome variations of contemporary percutaneous coronary interventions","volume":"113","author":"Moscucci","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2017.08.009_bib0060","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.urology.2016.05.071","article-title":"Identifying drivers of episode cost variation with radical prostatectomy","volume":"97","author":"Herrel","year":"2016","journal-title":"Urology"},{"author":"NCDR\u00ae CathPCI Registry\u00ae v4","key":"10.1016\/j.amjcard.2017.08.009_bib0065"},{"key":"10.1016\/j.amjcard.2017.08.009_bib0070","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1365-2125.2010.03669.x","article-title":"Pharmacokinetics, pharmacodynamics, safety and tolerability of multiple ascending doses of ticagrelor in healthy volunteers","volume":"70","author":"Butler","year":"2010","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.amjcard.2017.08.009_bib0075","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1592\/phco.29.9.1089","article-title":"Pharmacokinetics and pharmacodynamics of prasugrel, a thienopyridine P2Y12 inhibitor","volume":"29","author":"Dobesh","year":"2009","journal-title":"Pharmacother J Hum Pharmacol Drug Ther"},{"key":"10.1016\/j.amjcard.2017.08.009_bib0080","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1161\/CIRCULATIONAHA.116.023402","article-title":"Pharmacodynamic comparison of prasugrel versus ticagrelor in patients with type 2 diabetes mellitus and coronary artery disease: clinical perspective","volume":"134","author":"Franchi","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2017.08.009_bib0085","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1093\/eurheartj\/ehv744","article-title":"A head-to-head pharmacodynamic comparison of prasugrel vs. ticagrelor after switching from clopidogrel in patients with coronary artery disease: results of a prospective randomized study","volume":"37","author":"Rollini","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2017.08.009_bib0090","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1160\/TH13-05-0384","article-title":"Ticagrelor versus prasugrel in diabetic patients with an acute coronary syndrome","volume":"111","author":"Laine","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.amjcard.2017.08.009_bib0095","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0149-2918(02)85026-3","article-title":"Relationship between daily dose frequency and adherence to antihypertensive pharmacotherapy: evidence from a meta-analysis","volume":"24","author":"Iskedjian","year":"2002","journal-title":"Clin Ther"},{"key":"10.1016\/j.amjcard.2017.08.009_bib0100","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1016\/j.clinthera.2007.12.022","article-title":"Association between copayment and adherence to statin treatment initiated after coronary heart disease hospitalization: a longitudinal, retrospective, cohort study","volume":"29","author":"Ye","year":"2007","journal-title":"Clin Ther"},{"key":"10.1016\/j.amjcard.2017.08.009_bib0105","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/art.24114","article-title":"Compliance with biologic therapies for rheumatoid arthritis: do patient out-of-pocket payments matter?","volume":"59","author":"Curkendall","year":"2008","journal-title":"Arthritis Care Res"},{"author":"Lerner","key":"10.1016\/j.amjcard.2017.08.009_bib0110"},{"author":"Kass","key":"10.1016\/j.amjcard.2017.08.009_bib0115"},{"author":"United States Food and Drug Administration","key":"10.1016\/j.amjcard.2017.08.009_bib0120"},{"author":"United States Food and Drug Administration","key":"10.1016\/j.amjcard.2017.08.009_bib0125"},{"key":"10.1016\/j.amjcard.2017.08.009_bib0130","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12265-013-9527-3","volume":"7","author":"Schulz","year":"2014","journal-title":"J Cardiovasc Transl Res"},{"key":"10.1016\/j.amjcard.2017.08.009_bib0135","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1377\/hlthaff.2010.0526","article-title":"Regional collaborative of hospitals and physicians in Michigan cut costs and improved the quality of care","volume":"30","author":"Share","year":"2011","journal-title":"Health Aff (Millwood)"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914917313796?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914917313796?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T03:28:12Z","timestamp":1535426892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914917313796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0002914917313796"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2017.08.009","relation":{},"ISSN":["0002-9149"],"issn-type":[{"type":"print","value":"0002-9149"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ninety-Day Readmission and Long-Term Mortality in Medicare Patients (\u226565 Years) Treated With Ticagrelor Versus Prasugrel After Percutaneous Coronary Intervention (from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium)","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2017.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}